Supply of Naloxone Hydrochloride Injection Auto-Injectors

The contract entails the manufacture and supply of 60 units of Naloxone Hydrochloride 10 mg/0.4 mL auto-injectors, packaged in six groups of ten, specifically designed for rapid opioid overdose emergency response. Each unit must fully comply with FDA regulations and bear MMS No. 1 labeling to ensure regulatory adherence and clinical appropriateness in high-stakes situations. The product is intended for deployment in emergency settings where immediate intervention is critical, and the packaging configuration supports efficient distribution and field readiness. The contract is classified as a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325412 for pharmaceutical and medicinal product manufacturing. Although no specific delivery location or point of contact is provided, the award is linked to the DIBBS system under contract number SPE2DP26P1018, with the solicitation posted in July 2026, indicating a future procurement timeline.